Clarksville, MD, United States of America

Wenbin Tuo


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Wenbin Tuo

Introduction

Wenbin Tuo is a notable inventor based in Clarksville, MD (US). He has made significant contributions to the field of veterinary science, particularly in the development of vaccines against bovine neosporosis. His work has implications for livestock health and agricultural productivity.

Latest Patents

Wenbin Tuo holds 1 patent related to the causal agent of bovine neosporosis, which results in high levels of abortion in cattle. His research evaluated the protective efficacy of two antigens: cyclophilin (NcCyP) and NcSRS2. Mice vaccinated with recombinant NcCyP, rNcSRS2, and the combination of both antigens, formulated with the adjuvant ImmuMax-SR® and CpG, were challenge-infected three weeks after booster immunization. The results showed that mice receiving these vaccines developed high levels of NcCyP- or NcSRS2-specific antibodies. Notably, those vaccinated with either rNcCyP or the combination of rNcCyP and rNcSRS2 exhibited significantly higher protection compared to mock- or non-vaccinated mice.

Career Highlights

Wenbin Tuo is currently associated with the United States of America, as represented by the Secretary of Agriculture. His work focuses on developing effective vaccines that can protect livestock from infectious diseases, thereby enhancing agricultural practices.

Collaborations

Wenbin has collaborated with notable colleagues, including Mark C Jenkins and Yan Zhao. Their combined expertise contributes to the advancement of research in veterinary immunology.

Conclusion

Wenbin Tuo's innovative work in vaccine development for bovine neosporosis highlights his commitment to improving livestock health. His contributions are vital for the agricultural sector and demonstrate the importance of research in veterinary science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…